One-year efficacy and safety from a phase 3 trial of ravulizumab in adult patients with paroxysmal nocturnal hemoglobinuria receiving prior eculizumab treatment

Authors
Category Primary study
ConferenceBritish Journal of Haematology
Year 2020
This article has no abstract
Epistemonikos ID: 608e738e6f4b8762aef976225217abfbd4f6628c
First added on: Apr 30, 2026